Background: Allergic asthma is a CD4 T H 2-lymphocyte driven disease characterized by airway hyperresponsiveness and eosinophilia. B cells can present antigens to CD4 T cells and produce IgE immunoglobulins that arm effector cells; however, mouse models are inconclusive on whether B cells are necessary for asthma development. Objectives: We sought to address the role of B cells in a house dust mite (HDM)-driven T H 2-high asthma mouse model. Methods: Wild-type and B cell-deficient muMT mice were sensitized and challenged through the airways with HDM extracts. The antigen-presenting capacities of B cells were studied by using new T-cell receptor transgenic 1-DER mice specific for the Der p 1 allergen. Results: In vitro-activated B cells from HDM-exposed mice presented antigen to 1-DER T cells and induced a T H 2 phenotype. Invivo B cells were dispensable for activation of naive 1-DER T cells but necessary for full expansion of primed 1-DER T cells. At high HDM challenge doses, B cells were not required for development of pulmonary asthmatic features yet contributed to T H 2 expansion in the mediastinal lymph nodes but not in the lungs. When the amount of challenge allergen was decreased, muMT mice had reduced asthma features. Under these limiting conditions, B cells contributed also to expansion of T H 2 effector cells in the lungs and central memory T cells in the mediastinal lymph nodes. Conclusion: B cells are a major part of the adaptive immune response to inhaled HDM allergen, particularly when the amount of inhaled allergen is low, by expanding allergen-specific T cells. (J Allergy Clin Immunol 2017;140:76-88.) 
Allergic asthma is a chronic inflammatory disease of the conducting airways affecting 5% to 10% of the Western population. It is characterized by reversible airway obstruction, airway hyperresponsiveness, eosinophilia, and a CD4 T H 2 lymphocyte-dominated immune response associated with increased serum IgE levels against innocuous environmental allergens. [1] [2] [3] On allergen exposure, airway epithelial cells produce chemokines and innate cytokines, such as IL-1, thymic stromal lymphopoietin, GM-CSF, and IL-33, which instruct dendritic cells (DCs) and activate type 2 innate lymphoid cells. 3 In the lymph nodes DCs induce the differentiation of T H 2 cells and IL-21-and IL-4-producing follicular helper T (T FH ) cells, helped in this process by basophils. 4 In turn, T H 2-derived IL-4 activates B lymphocytes and promotes immunoglobulin class-switching to IgE. 1, 5 The most documented effector function of B cells is production of antigen-specific immunoglobulins, of which IgG, IgM, and IgA are far more abundant than IgE. Circulating IgE can bind to the high-affinity FcεRI receptor, and cross-linking of IgE-FcεRI complexes on mast cells and basophils leads to degranulation and immediate release of inflammatory mediators causing allergic symptoms, 6 whereas allergen focusing through IgE-armed FcεRI on DCs can decrease the threshold for allergen recognition and further promote T H 2 responses. 7 Although allergen-specific IgE is mostly considered pathogenic, allergenspecific IgG (particularly IgG 4 ) and IgA are believed to play a protective role by capturing and neutralizing allergens at the mucosal surface. [8] [9] [10] In addition to immunoglobulin production, activated B cells also play a role as accessory antigen-presenting cells (APCs), particularly when T cells are first primed by DCs when antigens are captured through the surface immunoglobulin receptor. [11] [12] [13] They might not be as potent as DCs in priming naive T cells, but still, their abundant presence in T cell-inductive sites, the production of cytokines that influence the activation and positioning of DCs and naive T cells, and their expression of surface molecules, such as CD86, inducible costimulator ligand, CD40 ligand, and OX40 ligand, endow B cells with relevant antigen-presenting and/or accessory functions to promote and sustain type 2 adaptive immune responses. [14] [15] [16] [17] [18] [19] The antigen-presenting and T H 2-promoting effects of B cells have been demonstrated in models of parasitic infection 16, 17, [20] [21] [22] and in T H 2-driven asthma models [23] [24] [25] [26] mainly using the model allergen ovalbumin, which requires injection of peritoneal alum adjuvant to boost T H 2 immunity. Even though a causal relationship between IgE and allergic asthma has long been recognized 27 and animal models of ovalbumin-driven asthma have revealed the contribution of different classes of immunoglobulins in mice, 28, 29 the role of B cells in the allergic process to natural allergens, such as house dust mite (HDM; Dermatophagoides pteronyssinus), remains elusive. The aim of this study was to establish the exact role of B cells in the course of HDM-induced allergic airway inflammation. HDM is the most prevalent cause of perennial allergic sensitization in asthmatic patients (50% to 85%) and derives its allergenic nature from mite-derived proteins that can be found in the excreta of mites. Mite fecal pellets, which are inhaled as small particles that contain fecal Toll-like receptor ligands and crude extracts of entire Dermatophagoides organisms, have the capacity to trigger epithelial cells and DCs of the lung, leading to T H 2 and T H 17 priming in the absence of adjuvant addition. [30] [31] [32] A major focus of our study was to understand how B cells contribute to antigen presentation to CD4 T cells, taking advantage of a newly developed T-cell receptor (TCR) transgenic mouse strain, the 1-DER mouse, in which all CD4 T cells are naive and react to a peptide found in the cysteine proteinase Der p 1 protein, a major allergen of HDM. 4, 32, 33 We found that B cells are massively recruited to HDM allergen-challenged lungs and mediastinal nodes, produce immunoglobulins reactive to HDM, and presented allergens to naive 1-DER T cells in vitro. In vivo, however, the contribution of B cells to the induction of cellular type 2 inflammation and asthmatic features was dependent on allergen dose and on the tissue site at which T H 2 cytokine production is probed. Only when the amount of allergen challenge dose was low, were B cells necessary for optimal expansion of HDM-reactive T H 2 and central memory T (T CM ) cells and for development of full-blown asthma features, such as eosinophilic airway inflammation and bronchial hyperreactivity (BHR).
METHODS Mice
C57BL/6 mice were purchased from Harlan (Indianapolis, Ind). B celldeficient muMT mice (C57Bl/6 background; Jackson Laboratory, Bar Harbor, Me) were bred at the animal facility of Ghent University Hospital. Wild-type (WT) or heterozygous littermates were used as control animals. 1-DER mice express an MHC class II-restricted TCR specific for Der p 1 on their CD4 T cells and were generated as previously described 4, 32 and maintained on the Rag2 2/2 background so that CD4 T cells had not seen any bystander
antigens. Experiments were approved by the animal ethics committee of Ghent University.
HDM asthma model
Mice were sensitized intratracheally with 1 mg of crude HDM extract (Greer Laboratories, Lenoir, NC) on day 1 and subsequently challenged with 10 mg of HDM extract intranasally on days 7 to 11 to induce allergic airway inflammation. In some experiments the challenge dose was decreased to 1 or 3 mg. Control mice received sham sensitization and challenge with PBS. Four days after the last challenge, mice were killed, and organs were collected for analysis. Bronchoalveolar lavage (BAL) was performed with 3 3 1 mL of PBS containing EDTA. Lungs were collected and frozen at 2808C for periodic acid-Schiff staining to evaluate lung inflammation and mucus cell metaplasia. Pictures were obtained with AnalySIS getIT (Olympus Soft Imaging Solutions GmbH, Hamburg, Germany). Muc5ac mRNA expression was measured in lung tissues to confirm mucus cell metaplasia. RNA was obtained by using the TriPure Isolation Reagent (Roche, Mannheim, Germany) and isolated according to the manufacturer's instructions. RNA was reverse transcribed with a Transcriptor High Fidelity cDNA Synthesis Kit (Roche), and samples were analyzed by using SYBR green-based RT-PCR with a LightCycler 480 system (Roche). PCR primers for Muc5ac and the reference genes Rpl13a, Hprt, and Sdha were as follows:
Muc5ac: forward GAGGCTCCCACATGTCCA, reverse TGAAGGC ATTACTGTCACAGGG; Rpl13a: forward CCTGCTGCTCTCAAGGTTGTT, reverse TGGT TGTCACTGCCTGGTACTT; Hprt: forward TCCTCCTCAGACCGCTTT, reverse CCTGGTTCATC ATCGCTAATC; and Sdha: forward TTTCAGAGACGGCCATGATCT, reverse TGGGA ATCCCACCCATGTT.
Single-cell suspensions were obtained for further analysis; lymph nodes and lungs were digested with Liberase TM and DNAse (both from Roche). For the measurement of airway hyperresponsiveness, mice were anesthetized with urethane, paralyzed with D-tubocurarine, and tracheotomized, followed by mechanical ventilation on a flexiVent machine (SCIREQ, Montreal, Quebec, Canada). Increasing concentrations of methacholine were administered through a jugular vein catheter (0-200 mg/mL) or nebulized (0-400 mg/mL). Dynamic resistance and compliance were recorded after a standardized inhalation maneuver given every 10 seconds for 2 minutes. Baseline resistance was restored before administering the subsequent doses of methacholine.
T H 2 cytokine assessment
To analyze T H 2 cytokine secretion, 2 3 10 5 mediastinal lymph node (MLN) cells/well were restimulated for 3 days with 30 mg/mL HDM extract. Cytokine production was measured in supernatants by using cytokine-specific ELISAs (Ready-Set-Go Kits; eBioscience, San Diego, Calif). In some experiments splenic or lymph node-sorted CD19 1 B cells (2 3 10 5 , >95% pure) or GM-CSF bone marrow-derived DCs (2 3 10 4 ) cultured, as previously described, 34 were added to HDM-restimulated MLN cells. To analyze cytokine production by means of intracellular cytokine staining, 50 ng/mL PMA and 1 mmol/L ionomycin (both from Sigma, St Louis, Mo) were added to cultures of total MLNs or lung cells for 3 hours in the presence of BD GolgiStop (BD Biosciences, San Jose, Calif). The BD Fixation/ Permeabilization buffer set was used for intracellular staining of cells.
B-and T-cell cocultures
1-DER T cells were isolated from spleens and lymph nodes of Rag 
T-cell adoptive transfer
Naive or primed 1-DER T cells (CD45.1) were isolated as above, labeled with Cell Trace Violet (Invitrogen), and injected into CD45.2 WT or muMT recipients through the tail vein. After transfer, mice were inoculated with HDM, as described. Acquisition was performed on an LSR Fortessa cytometer (BD Biosciences). Cell sorting was performed on a FACSAria II cytometer, and after cell sorting, purity was checked (always >95%).
Flow cytometry and antibodies

Statistical analysis
All data are represented as means 6 SEMs. Statistical significance between groups was calculated with ANOVA multiple comparison analysis, Mann-Whitney U testing, or both by using GraphPad Prism software (GraphPad software, La Jolla, Calif).
Lung function transfer resistance values were log-transformed and analyzed as repeated measurements by using the residual maximum likelihood, as implemented in Genstat v18 (VSN International; Hemel Hempstead, United Kingdom; Payne et al 35 ) . A linear mixed model was fitted to the data, with time points set as equally spaced. The antedependence correlation structure of order 2 was selected as best model fit based on the Akaike information coefficient. The significance of the main (genotype, treatment, and time) and all possible interaction effects was assessed by using an F-test. The experiment was set up as a randomized block design.
RESULTS
B-cell accumulation in HDM-sensitized and challenged mice
HDM is an important human allergen, and when instilled in airways of previously sensitized mice (Fig 1, A) , it induces allergic airway inflammation with features resembling those of human T H 2-high allergic asthma, such as eosinophilia in BAL fluid (see Fig E1, A, in this article's Online Repository at www. jacionline.org), goblet cell metaplasia (GCM; see Fig E1, B) , increased production of T H 2 cytokines in MLN cultures (see Fig E1, C) , and an increase in serum IgG 1 and IgE levels (Fig 1, B) not seen in control animals that were sham PBS sensitized and PBS challenged. The levels of IgE induced were sufficient to arm FcεRI-expressing effector cells, such as mast cells, basophils, and inflammatory DCs with surface IgE (Fig 1,  C , and see Fig E2 , C, in this article's Online Repository at www.jacionline.org).
To assess the contribution of B cells to HDM-related allergic airway inflammation, we studied their distribution in MLNs and lungs in steady state (PBS) and after HDM challenge. In the control situation naive B cells made up the majority of B cells in the lymph nodes and lung. HDM treatment induced a strong increase in total B-cell numbers both in MLNs and lungs (10-and 18-fold increase, respectively ; Fig 1, D-G) . In addition to the massive influx of naive B cells, we found on average 12.2% GL7 (Fig 1, E and G, and see Fig E2, A) . Germinal center B cells were less abundant in the lungs but still accounted for 62% of total lung B cells (Fig 1, E and G, and see Fig E2, A) in HDM-treated mice, whereas this was less than 0.3% in PBStreated mice.
Lung immunofluorescence staining revealed B220 (Fig 2, C) .
We further observed that ex vivo-sorted B cells from mice with HDM allergy did not stimulate 1-DER T-cell division in the absence of exogenous Der p 1 protein, suggesting that the amount of antigen captured, processed, or both in vivo was very low and less than the detection limit of the assay. In support of this, we found that fluorescently labeled HDM extract could not be recovered in MLN B cells after intratracheal injection, whereas it could be readily detected in MLN DCs (Fig 2, D) . In conclusion, B cells isolated from the airways of HDM-sensitized and challenged mice are capable APCs and can induce 1-DER T H 2, T H 1, and T FH cell differentiation in vitro but only when exogenous antigen is supplied.
B cells are not required for initial expansion of allergen-reactive T cells in vivo
The fact that B cells sorted ex vivo 3 days after allergen encounter did not present in vivo-captured antigen to 1-DER T cells could be due to rapid downregulation of MHC-peptide complexes, as previously described to occur within 24 hours in B cells presenting antigen to cognate CD4 T cells. 13 Therefore we also performed an in vivo antigen presentation experiment in B cell-deficient muMT mice. These mice lack mature B cells because of the absence of the IgM membrane domain, which is necessary for positive selection of immature B cells. 36 Naive CD45.1 Rag 2/2 1-DER T cells were adoptively transferred into naive CD45.2 muMT mice receiving HDM extract to study sensitization (Fig 2, E) . In this setting 1-DER T-cell division in muMT mice measured at 3 days mirrored that in WT mice (Fig 2, F) , with comparable proliferation indexes (Fig 2, G) and CD44 upregulation (Fig 2, H) observed in MLNs and lungs. These data demonstrate that B cells are not necessary for mounting primary T-cell responses to HDM, at least in part because they do not take up antigen in vivo.
B cells are not necessary for the development of asthma features to standard HDM allergen
Although antigen presentation to naive allergen-reactive T cells was not affected by the lack of B cells in muMT mice, it was still important to study the effect of B-cell deficiency on features of asthma because immunoglobulins are crucial for arming asthma effector cells, such as basophils and mast cells, with IgE. However, it has been reported that muMT mice can still have B cells through an IgM-independent pathway and can even secrete IgE antibodies in conditions of inflammation. [37] [38] [39] We first tested whether B cells were absent from the lungs of muMT mice subjected to a protocol of HDM-induced asthma induced by challenge of the lungs with 10 mg of HDM extract. We found only trace amounts of B cells in both the lungs and MLNs of muMT mice, (Fig 3, A and B , and see Fig E3, A and B, in this article's Online Repository at www.jacionline.org), demonstrating the absence of any IgM-independent B-cell populations. Compared with WT littermates, serum and BAL fluid IgE, IgG 1 , and IgA levels were extremely low to absent in muMT mice and did not increase on HDM treatment (Fig 3, C and D , and see Fig E3, C) . HDM-specific IgG 1 was also not detectable in muMT sera, although it was in WT sera (see Fig E3, C) .
To verify the absence of IgE, we checked the occupancy of FcεRI on basophils in blood and lungs by means of IgE surface staining. Surface IgE staining was significantly down on basophils of muMT mice compared with that in WT mice (Fig 3, E and F, and see Fig E4 in this article's Online Repository at www.jacionline.org), confirming the near-complete absence of IgE in muMT mice. We further confirmed that muMT mice had a block in T FH cell development in the MLNs in response to HDM (Fig 3, G) , as expected in the absence of B cells in muMT mice. Unexpectedly, HDM-treated muMT mice had similar levels of eosinophilia in BAL fluid (Fig 3, H) and GCM comparable with those in their WT littermates (Fig 3, I) . Lung function was measured by assessing BHR to methacholine. HDM-treated muMT mice exhibited a (nonsignificant) trend toward lower BHR at intermediate methacholine doses, but at the highest dose tested, they reacted comparably to WT mice (Fig 3, J) . Altogether, these results establish that even though muMT mice lack B cells and immunoglobulins, they experience HDMinduced airway inflammation comparable with that in WT mice, demonstrating the redundancy of B cells in this standard dose model of HDM-related asthma.
B cells are necessary for stimulating cytokine production in MLNs
Although induction of pulmonary eosinophilia is a reflection of adequate adaptive T H 2 cell immunity to HDM in B cell-deficient mice, we still measured T H 2 and T H 1 cytokine production after in vitro HDM restimulation of MLN lymphocytes. Levels of the T H 2 cytokines IL-4, IL-5, and IL-13, as well as IL-10 and IFN-g, were all drastically reduced in muMT MLN cultures compared with WT cultures (Fig 4, A) . the ideal experiment to address whether these effects in muMT mice were indeed solely due to lack of B cells would be to reconstitute muMT mice with B cells in vivo. However, previous work, 40, 41 as well as our own experience, has shown that adoptively transferred B cells are rejected in muMT mice a few days after injection, precluding such an in vivo reconstitution experiment. Therefore we took an ex vivo approach and complemented restimulated muMT lymphocyte cultures with either naive MLN B cells from unmanipulated WT mice or B cells isolated from MLNs of HDM-treated WT mice. Results in Fig 4, B, show that addition of naive B cells only marginally increased T H 2 cytokine production, whereas antigen-primed B cells were able to partially restore T H 2 cytokine production. The addition of DCs was also able to restore T H 2 cytokine production in muMT cultures, as previously reported by others. 40 Naive B cells were as capable as bone marrow-derived DCs to restore IL-10 and boosted IFN-g production of muMT lymphocytes above WT levels (see Fig E5, A, in this article's Online Repository at www. jacionline.org). Supplementation of WT HDM MLN lymphocyte cultures with exogenous bone marrow-derived DCs also boosted their T H 2 secretion (see Fig E5, B) , whereas no T H 2 cytokines were detected when MLN cultures from PBS-treated WT mice . P values shown in graphs were calculated by using the Dunn multiple comparisons test after ordinary ANOVA comparing WT against the different muMT conditions. C, WT and muMT mice received the full HDM asthma model, as shown in Fig 1, A. On day 15, CD4 1 T cells from BAL fluid and MLNs were stimulated with PMA and ionomycin for 3 hours before performing intracellular staining for IL-4, IL-5, IL-13, and GATA-3. Numbers were calculated based on trypan blue viability counts. *P 5 .01-.05, **P 5 .001-.01, and ***P < .001.
were supplemented with APCs (see Fig E5, C) . The need for exogenous APC for in vitro T H 2 cytokine production could result from a scarcity of DCs in the MLNs of muMT mice, as has been described by others. 42 However, the frequency and numbers of CD11c
1
MHCII
hi DCs in the MLNs of muMT mice were comparable with those in WT mice after both sensitization and induction of HDM-driven asthma (see Fig E6 in this article' s Online Repository at www.jacionline.org).
Finally, we evaluated in vivo T H 2 responses by performing intracellular staining for T H 2 cytokines and the T H 2 lineage transcription factor GATA-3 on BAL fluid and MLN lymphocytes. We found that BAL fluid of HDM-treated muMT mice contained normal numbers of T H 2 cytokine-secreting and GATA-3 1 CD4 1 effector T cells compared with WT littermates (Fig 4, C) . In the MLNs, however, MuMT mice presented significantly less IL-4-expressing and GATA-3
1
CD4
1 T cells (Fig 4, D) , most likely representing T FH cells. Altogether, these data demonstrate that B cells are necessary for mounting full-blown cytokine responses in the MLNs during inhaled allergen HDM challenges.
B cells are necessary for full expansion of primed 1-DER T cells during secondary allergen challenge
Primed CD45.1 Rag 2/2 1-DER T cells were adoptively transferred into already sensitized CD45.2 muMT mice immediately before receiving 5 daily HDM doses to study how the lack of B cells might reduce the cytokine response to inhaled HDM allergen challenge in the lymph nodes (Fig 5, A) . In this setting primed 1-DER T cells divided significantly less in MLNs, lungs, and spleens of muMT mice compared with WT mice (Fig 5, B) . Although the proportion of divided cells was only marginally lower in muMT mice (on average: 89.5% in muMT vs 97.6% in WT MLNs), the number of divisions that T cells underwent was significantly reduced, as shown by the substantially reduced proliferation index (on average: 11.4 vs 4.5 in WT and muMT MLNs; Fig 5, C) . The proliferation index of 1-DER T cells in MLNs of muMT mice resembled that of 1-DER T cells in nondraining nodes of WT mice. Furthermore, 1-DER T cells from muMT mice were less activated, as evidenced by reduced expression of the CD44 T-cell activation marker (Fig 5, B and  D) . In conclusion, expansion and activation of previously primed allergen-specific T cells occurred much less efficiently in the MLNs of B cell2deficient muMT mice.
Role for B cells in HDM-driven asthma is revealed by limiting the allergen challenge dose
We next reasoned that the reduced expansion of allergenspecific T cells observed in muMT MLNs was not translating into reduced airway inflammation because the dose of challenge J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 allergen used in the experimental setup was sufficient either for local antigen presentation to primed resident T H 2 cells in the lung effector site 43, 44 or that the few MLN-expanded effector T cells that still made it to the lung (Fig 4, C) were sufficient to mediate airway inflammation when challenged with standard doses of allergen. To address whether eosinophilia in B cell-deficient mice was influenced by allergen dose, we titrated the dose of challenge allergen administered over a period of 5 days. Although muMT mice challenged with 10 mg of HDM extract had identical eosinophil influx in the lungs compared with WT mice, those challenged with 3 mg doses had reduced eosinophil influx compared with WT mice (Fig 6, A) . As for the standard-dose challenge, this was supported by a strong decrease in the production of T H 2 and T H 1 cytokine levels by MLNs on in vitro HDM restimulation with low-dose allergen challenge (Fig 6,  B) . We verified that serum IgG 1 and IgE levels in muMT mice treated with 3 mg of HDM were still low compared with those of WT littermates (Fig 6, C) . In line with reduced BAL eosinophilia, BHR to methacholine challenge was reduced in low-dose HDM-challenged muMT mice compared with that in WT mice (P < .05; Fig 6, D) .
An unanticipated finding was that low-dose HDM muMT mice exhibited identical levels of GCM (measured by Muc5ac mRNA induction) compared with WT mice (Fig 6, E) , despite clearly reduced levels of the GCM-inducing cytokine IL-13. Thus GCM seems to be B cell independent.
In line with decreased BAL eosinophilia and severely reduced in vitro MLN T H 2 cytokine production, T H 2 cytokine-producing T-cell counts were significantly reduced both in BAL fluid and MLNs from muMT mice receiving low-dose HDM compared with their WT littermates (Fig 6, F) . As in mice receiving standard HDM challenge doses, proliferation and activation of adoptively transferred primed CD45.1 Rag 2/2 1-DER T cells was lower in muMT mice compared with values in WT mice receiving low-dose HDM (Fig 6, G) . In conclusion, we demonstrated that the role for B cells in HDM-induced asthma features is to be revealed only when the dose of challenge allergen is low, as a consequence of a decrease in the number of T H 2 effector cells in the lung effector site of muMT mice.
It has been shown that during secondary immune responses to allergen, there is continued need for new waves of effector cells generated in the draining MLNs from recirculating T CM cells, fueling the ongoing response with new effector cells. 43, 45 In addition, pathogenic T H 2 cells were found to be lung-resident memory T (T RM ) cells that depend on IL-2 signaling and are increased in the absence of B cells. 44 Therefore, as a final investigation, we explored whether lack of B cells altered the differentiation of 1-DER T cells to become either T CM or T RM cells. Therefore naive CD45.1 1
Rag
2/2 1-DER T cells were adoptively transferred into WT or muMT hosts, which subsequently underwent the full HDM protocol with low-dose antigen and were left untreated for 3 weeks (Fig 7, A) . We used a brief intravenous labeling with an antibody directed against the panleukocyte marker CD45 to label all cells that were still in the bloodstream and could therefore not be considered ''resident'' cells of the lungs. 46 First, 1-DER T cells persisted at similar numbers in muMT and WT MLNs and lungs (Fig 7, B) , suggesting that B cells do not influence the overall survival of 1-DER T cells after adoptive transfer. Additionally, lung resident CD45 iv2 CD4 1 CD44 hi 1-DER T cells were present at normal frequencies in muMT compared with WT mice (Fig 7, C, 
CD44
1 T CM 1-DER cells in the MLNs of muMT mice 3 weeks after the last challenge, and 1-DER T cells expressed less CD69 and CD44 compared with WT (Fig 7, D, and see  Fig E7, B) . These data demonstrate that in a low-dose HDM challenge model, lack of B cells mainly affects generation of T CM cells while leaving T RM formation intact.
DISCUSSION
Here we set out to dissect the role of B cells in a mouse model of HDM-induced allergic asthma, with a focus on antigen presentation. The use of HDM-specific 1-DER T cells in vivo allowed us to directly (and for the first time) address the antigen-presenting capacities of B cells to both naive and primed allergen-specific T cells and to follow their fate in mice lacking B cells. We ventured to do this because the available literature on the role of B cells in asthma mouse models is discordant, with some groups reporting that B cells are essential for BHR only, 46 and others demonstrating that B cells are redundant for the development of eosinophilic airway inflammation, BHR, or both. [23] [24] [25] [26] 38, 48, 49 At the same time, some of those groups reported normal T H 2 cytokine production, 26 ,48 whereas others reported reduced T H 2 cytokine counts in B cell-deficient mice. 16, 25, 47, 49 These discrepant findings were largely explained as the result of intrinsic differences in model setup (number and timing of allergen doses), mouse strain (muMT or JH 2/2 on BALB/C or Bl6 background), and antigen (OVA, HDM, Aspergillus species, cockroach, or a mixture).
The controversy in this field has recently been fired up by 2 high-profile articles addressing the role of B cells in HDM-related asthma. 44, 50 Ballesteros-Tato et al 50 found muMT mice to have impaired pulmonary T H 2 effector responses because of a defect in the formation of T FH cells, which were proposed by this group to be the immediate progenitors of effector T H 2 cells. To the contrary, like us, Hondowicz et al 44 observed that B cells are dispensable for pulmonary effector responses and BHR. The mechanistic explanation offered by this group was that defective T FH cell differentiation caused by a lack of B cells favors differentiation of CD4 T cells to an alternative fate of cytokineproducing T RM cells that can mediate asthma features on allergen encounter. Our findings in an inhaled HDM model of asthma in C57Bl/6 mice resolves an important part of this recent controversy by showing that the degree to which airway eosinophilia and T H 2 cytokine production is affected in B celldeficient animals is dose dependent and that conclusions and mechanistic explanations offered will also heavily depend on the precise location at which T H 2 cytokine production is measured.
Mechanistically, we show that lack of B cells mainly affects the proliferation of primed allergen-specific CD4 T cells in the mediastinal nodes. Because the amount of T RM cells developing from a pool of naive Der p 1-specific T cells was normal in mice lacking B cells (despite a dramatic reduction in T FH cell differentiation), we believe that lack of expansion of primed T cells is the main explanation for the decrease in lung T H 2 cytokine-producing cells and consequent asthma development when the amount of recall allergen is limiting. Rescue of ex vivo cytokine production of MLNs by exogenous APCs, together with normal frequencies of T H 2-producing cells in muMT MLNs, demonstrates that muMT T cells indeed harbor the potential to produce T H 2 cytokines but that there is an intrinsic defect in stimulation, most likely caused by defective antigen presentation.
We have previously shown that in the sensitization setting DCs are sufficient for T H 2 priming, 33, 51 and our current data demonstrate that this holds true in the absence of B cells. In the challenge setting in the absence of B cells, on the other hand, we assume that DCs become limiting to present the available allergen to primed 1-DER T cells especially in the MLNs, where allergen-reactive T cells massively expand after a few days of proliferation. In that situation bystander B cells, which were also activated on HDM exposure (Fig 1, GC reaction ; upregulation of MHC class II and the costimulatory molecule CD86; M. Dullaers, unpublished data), could further amplify 1-DER T-cell responses, allegedly by providing additional MHC class II molecules. 40 This concept is supported by in vitro experiments by us and others 40 showing that either B cells or DCs could rescue T H 2 function of muMT MLN T cells. Impaired T H 2 responses in B cell-deficient mice were also reported in various other model systems. 14, 16, 25, 40, 47, 49 A lack of proper T H 2 expansion emerged as a mechanistic explanation in a T H 2 model of keyhole limpet hemocyanin/alum vaccination, in which in vivo reconstitution of muMT mice with either activated splenic B cells or DCs could restore short-term (<5 days) CD4 T-cell expansion and T H 2 differentiation. 40 Likewise, chimeric mice lacking MHC class II only on B cells showed defects in T-cell expansion and differentiation toward T H 2 cells. 50, 52 The fact that HDM-specific B cells, but not naive B cells, partially restored T H 2 cytokine secretion in our muMT MLN restimulations could be related to the activation status of the B cells or their enhanced antigen uptake capacity through an HDM-specific B-cell receptor. In support of this, we found that B cells taken from HDM-exposed mice had higher levels of the costimulatory molecule CD86. Unfortunately, we could not perform in vivo reconstitution experiments with B cells in muMT mice because B cells are rapidly rejected in these mice and do not survive well beyond 5 days. 40, 41 In our experiments we found that B cells sorted from MLNs of HDM-exposed mice contained only minute amounts of HDM allergen, generating a conceptual problem because antigen presentation is virtually always preceded by antigen uptake. Because we performed this experiment on a pool of polyclonal B cells, we cannot fully exclude that HDM-specific B cells would be more adept to take up HDM antigen and stimulate HDM-specific T cells. Furthermore, B cells were shown to take up papain (a T H 2-inducing protease) after footpad injection and subsequently amplified T H 2 responses in the draining lymph nodes in an inducible costimulator ligand-dependent matter. 18 This non-Bcell receptor-mediated phenomenon seems to be specific for papain because OVA administered through the same route was not taken up by B cells. Our group has preliminary evidence that proteolytic activity of allergens is decisive as to whether they leak through the airway epithelium. It is very likely that the enzyme papain gains access to B cells in the lymph nodes after footpad injection by leaking into the lymphatics, whereas in our model most HDM reaches the lymph nodes in a CCR7-dependent manner, requiring DCs. 33 Together, our data reveal that the dose of allergen during secondary challenge of already primed mice is decisive irrespective of whether a lack of B cells and concomitant reduction in the expansion of T H 2 cells in the MLNs also leads to reduced airway inflammation. We believe that with standard doses of allergen challenge, B cells are redundant because local antigen presentation by inflammatory and conventional DCs to tissueresident memory T H 2 cells (the formation of which is fully intact in B cell-deficient mice) 33 is sufficient to cause full-blown airway eosinophilia. In support of this hypothesis, with standard-dose HDM, we found normal numbers of CD4 1 T cells and T H 2-producing T cells in the lung effector site, probed in the BAL compartment, in the face of a profound decrease in CD4 1 T-cell and T H 2 cell numbers in MLNs of muMT mice. It has been shown that during secondary immune responses to allergen, there is continued need for new waves of effector cells generated in the draining MLNs from recirculating T CM cells or lymph noderesident T effector memory cells, fueling the ongoing tissue response with new effector cells that migrate to the lung. 43, 45 Our current work reveals that expansion of such primed T H 2 effector cells, as well as T CM cells in the MLNs, requires B cells in addition to migratory DCs. 45, 53 By decreasing the amount of allergen during challenge, we observed that effector responses became more dependent on these ''new recruit'' effectors. Consequently, in the absence of B cells, insufficient T H cell expansion in the MLNs leads to a lack of new effectors and a decrease in airway eosinophilia, BHR, and T H 2 effector cell counts in the lungs of muMT mice. Further work is needed to fully understand the effect of B cells in asthmatic patients. Lack of B cells and secreted immunoglobulins in muMT mice subjected to asthma also came with a lack of IgE on effector cells, such as basophils and mast cells. A causal relationship between B cell-derived IgE and allergic asthma in human subjects has long been recognized, 27 and anti-IgE therapeutics are being used successfully for treatment of severe allergic asthma, suggesting an important role for B cell-derived IgE in human asthma. 54 Therefore it is also possible that on reduction of the allergen dose in muMT mice, the enhancing effect of IgE ''arming'' of these effector cells became relatively more important. Because there are many parallel paths to causing tissue eosinophilia, B cell-deficient mice would see reductions in tissue inflammation because of a lack of adequate effector function of basophils and mast cells only when the amount of allergen is decreased. Alternatively, DCs might also use the high-affinity IgE receptor to capture allergens more efficiently, and this effect might see its major consequence only if the amount of allergen is limiting. 7 Studies are underway in our laboratory to dissect these roles of FcεRI on various cell types in the HDM model.
Because the heterogeneity of human asthma is as wide-ranging as the mouse models mentioned above, we assume that B cells will contribute to asthmatic features in some patient groups but probably not in all. This remains to be investigated further but is certainly supported by the observation that the clinical effectiveness of anti-IgE therapies in human asthmatic patients is also only seen in 30% to 40% of cases. Based on our findings, we predict that asthma therapies aimed at B cells (including anti-IgE strategies) will work best when combined with allergen avoidance measures.
Taken together, we show here, using a novel TCR transgenic model to read out HDM-specific T-cell responses, that B cells are dispensable for primary CD4
1 T-cell responses yet crucial for optimal expansion of primed T H 2 cells and generation of T CM cells in the MLNs. Only when the amount of inhaled allergen is limiting does the enhancement of T-cell effector responses by B cells (or their derived products) become crucial for optimal induction of asthma features.
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